Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges Ahead
Arun Kumar,
Biao Chang and
Irene Xagoraraki
Additional contact information
Arun Kumar: Department of Civil Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi 110016, India
Biao Chang: School of Civil and Environmental Engineering, Georgia Institute of Technology, 215 Sustainable Education Building, 788 Atlantic Drive NW, Atlanta, GA 30332, USA
Irene Xagoraraki: Department of Civil and Environmental Engineering, A124 Engineering Research Complex, Michigan State University, East Lansing, MI 48824, USA
IJERPH, 2010, vol. 7, issue 11, 1-25
Abstract:
This study identified existing issues related to quantitative pharmaceutical risk assessment (QPhRA, hereafter) for pharmaceuticals in water and proposed possible solutions by analyzing methodologies and findings of different published QPhRA studies. Retrospective site-specific QPhRA studies from different parts of the world (U.S.A., United Kingdom, Europe, India, etc. ) were reviewed in a structured manner to understand different assumptions, outcomes obtained and issues, identified/addressed/raised by the different QPhRA studies. Till date, most of the published studies have concluded that there is no appreciable risk to human health during environmental exposures of pharmaceuticals; however, attention is still required to following identified issues: (1) Use of measured versus predicted pharmaceutical concentration, (2) Identification of pharmaceuticals-of-concern and compounds needing special considerations, (3) Use of source water versus finished drinking water-related exposure scenarios, (4) Selection of representative exposure routes, (5) Valuation of uncertainty factors, and (6) Risk assessment for mixture of chemicals. To close the existing data and methodology gaps, this study proposed possible ways to address and/or incorporation these considerations within the QPhRA framework; however, more research work is still required to address issues, such as incorporation of short-term to long-term extrapolation and mixture effects in the QPhRA framework. Specifically, this study proposed a development of a new “mixture effects-related uncertainty factor” for mixture of chemicals ( i.e. , mixUF composite ), similar to an uncertainty factor of a single chemical, within the QPhRA framework. In addition to all five traditionally used uncertainty factors, this uncertainty factor is also proposed to include concentration effects due to presence of different range of concentration levels of pharmaceuticals in a mixture. However, further work is required to determine values of all six uncertainty factors and incorporate them to use during estimation of point-of-departure values within the QPhRA framework.
Keywords: human health; pharmaceuticals; mixture toxicity; risk assessment; uncertainty (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2010
References: View complete reference list from CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
https://www.mdpi.com/1660-4601/7/11/3929/pdf (application/pdf)
https://www.mdpi.com/1660-4601/7/11/3929/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:7:y:2010:i:11:p:3929-3953:d:10127
Access Statistics for this article
IJERPH is currently edited by Ms. Jenna Liu
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().